Deal Details
Eurofins Digital Testing Is Acquired by Stirling Square
Summary
Eurofins Scientific (“Eurofins”) (EUFI.PA) has agreed to sell its Digital Testing business (“Eurofins Digital Testing”) to Stirling Square Capital Partners (“Stirling Square”) for €220m on a cash and debt free basis. This business contributes approximately 1 percent of the Eurofins' sales and employs over 600 staff. The transaction is subject to various regulatory approvals and customary closing conditions.
Baird served as the exclusive financial advisor to Eurofins Scientific on this transaction.
About
Eurofins is Testing for Life. Eurofins is the global leader in food, environment, pharmaceutical and cosmetic product testing, and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. Eurofins is also a market leader in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in BioPharma Contract Development and Manufacturing. With over 61,000 staff across a decentralised and entrepreneurial network of 940 laboratories in 59 countries, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of a wide range of products, as well as providing innovative clinical diagnostic testing services and in-vitro diagnostic products.Eurofins Digital Testing was established in 2015 and has increased substantially in size and profitability over the past few years through organic growth, strategic investments and bolt-on acquisitions to expand its range of digital testing tools and services as well as its global reach. Eurofins Digital Testing provides global testing, quality assurance and technical analysis of digital systems, devices, content and cyber security. Eurofins Digital Testing is recognised as one of the leading players in its space in terms of technology, innovation and service quality.
Stirling Square Capital Partners was established in 2002 as a pan-European private equity firm which invests in mid-market companies with enterprise value of €100m to €500m. Stirling Square manages over €2.5bn on behalf of a global and diverse investor base.
CONTACT US TO LEARN MORE
- Date
- September 2022
- Company
- Eurofins Scientific
- Transaction
- M&A - Sellside
- Sectors
-
Technology & Services
Industrial - Verticals
-
Test, Measurement & Automation
IT Services, Security & Infrastructure
Testing, Inspection, Certification & Compliance ("TICC")
- Target Geography
- Europe
- Acquiror Geography
- Europe
Share
